Results 1 to 10 of about 12,731 (237)

HLA variation associated with peanut allergy and anaphylaxis among non-Hispanic Black individuals [PDF]

Journal of Allergy and Clinical Immunology: Global
Background: Peanut is a major cause of food allergy. HLA genes have been consistently associated with peanut allergy in association studies. To date, however, there have been very few genetic studies of peanut allergy in non-Hispanic Black (Black ...
Baojun Wu, PhD, Mao Yang, MS, Donglei Hu, PhD, Ray Zhang, Bin Liu, PhD, MPH, Samantha Hochstadt, MS, David E. Lanfear, MD, MS, Jonathan Witonsky, MD, MAS, Rajesh Kumar, MD, MS, Jill A. Hollenbach, PhD, MPH, Esteban G. Burchard, MD, MPH, Elad Ziv, MD, L. Keoki Williams, MD, MPH, MBA   +12 more
doaj   +2 more sources

Peanut-specific IgG subclasses as biomarkers of peanut allergy in LEAP study participants [PDF]

World Allergy Organization Journal
Antigen-specific IgG2 and IgG3 are rarely measured in food allergy clinical trials despite known function in preventing mast cell and basophil activation.
Carolyn H. Baloh, MD, Noha Lim, Michelle Huffaker, Pooja Patel, Jody Tversky, George Du Toit, MB, BCh, Gideon Lack, MB, BCh, Tanya M. Laidlaw, Donald W. MacGlashan   +8 more
doaj   +2 more sources

Long Non-Coding RNAs Expressed in the Peanut Allergy for Understanding the Pathophysiology of Peanut Allergy Rat Model [PDF]

Foods, 2022
Background: Peanut allergy (PA) has become a clinical and public health problem, which is mainly regulated by genetics, immune responses, and environmental factors.
Manman Liu, Sen Li, Boya Li, Shanfeng Sun, Guirong Liu, Junjuan Wang, Mengzhen Hao, Huilian Che   +7 more
doaj   +2 more sources

Peanut Allergy: An Overview [PDF]

Allergy, Asthma & Clinical Immunology, 2008
Peanut allergies have been increasing in prevalence in most industrialized countries. Onset is typically in early childhood, with a trend towards earlier ages of presentation.
Al-Ahmed Nasser, Alsowaidi Shirina, Vadas Peter   +2 more
doaj   +4 more sources

Assessing pediatric clinician adherence to the guidelines for prevention of peanut allergy: a natural language processing study [PDF]

BMC Medical Informatics and Decision Making
Background Early introduction of peanut products to infants around 4- to 6- months of age may reduce peanut allergy incidence. However, clinician adherence to the National Institute of Allergy and Infectious Diseases’ 2017 Addendum Guidelines for the ...
Anthony F. Wong, Lucy A. Bilaver, Jialing Jiang, Yuan Luo, Ruchi S. Gupta, Marc Rosenman, Michael S. Carroll   +6 more
doaj   +2 more sources

Developing a Prediction Model for Determination of Peanut Allergy Status in the Learning Early About Peanut Allergy (LEAP) Studies. [PDF]

J Allergy Clin Immunol Pract, 2023
Sever ML, Calatroni A, Roberts G, du Toit G, Bahnson HT, Radulovic S, Larson D, Byron M, Santos AF, Huffaker MF, Wheatley LM, Lack G.   +11 more
europepmc   +3 more sources

Viral Vector Based Immunotherapy for Peanut Allergy [PDF]

Viruses
Food allergy (FA) is estimated to impact up to 10% of the population and is a growing health concern. FA results from a failure in the mucosal immune system to establish or maintain immunological tolerance to innocuous dietary antigens, IgE production ...
Miguel Gonzalez-Visiedo, Roland W. Herzog, Maite Munoz-Melero, Sophia A. Blessinger, Joan M. Cook-Mills, Henry Daniell, David M. Markusic   +6 more
doaj   +2 more sources

Development of a mini pig model of peanut allergy [PDF]

Frontiers in Allergy
IntroductionThe prevalence of peanut allergies is increasing, emphasizing the need for an animal model to enhance our understanding of peanut allergy pathogenesis and to advance diagnostic tools and therapeutic interventions.
Akhilesh Kumar Shakya, Brittany Backus, Lazar D. Nesovic, Malini Mallick, Olivia Banister, Carla M. Davis, Sara Anvari, Harvinder Singh Gill   +7 more
doaj   +2 more sources

Safety and adherence of early oral immunotherapy for peanut allergy in a primary care setting: a retrospective cross-sectional study [PDF]

Allergy, Asthma & Clinical Immunology
Background Peanut allergy is a common food allergy with potentially life-threatening implications. Early oral immunotherapy for peanut allergy (P-EOIT) has been shown to be effective and safe in research and specialty clinic settings. Provision of P-EOIT
Victoria Landry, Rachel Lewis, William Lewis, Lyndsey MacDonald, Beth Carson, Kavish Chandra, Jacqueline Fraser, Andrew J. Flewelling, Paul Atkinson, Chris Vaillancourt   +9 more
doaj   +2 more sources

Risk subgroups and intervention effects among infants at high risk for peanut allergy: A model for clinical decision making. [PDF]

Clin Exp Allergy
Li Y, Devonshire A, Huang B, Andorf S.
europepmc   +3 more sources